NEWSPAPER PUBLICATION OF UNAUDITED RESULTS FOR THE QUARTER ENDED 30.06.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has informed the Bombay Stock Exchange that it published the extract of its unaudited financial results for the quarter ended 30 June 2025 in two newspapers — Free Press (English) and Choutha Sansar (Hindi) — on 8 August 2025. This is a routine compliance filing under Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The letter was signed by Sudhir Sethi, Chairman & Director (DIN: 00090172). The actual financial numbers are not part of this filing; they were published separately in the newspapers as required.
This is a standard regulatory disclosure with no direct impact on shareholders or stock price. It simply confirms that the company's Q1 FY26 results, already filed with the exchange, have also been published in newspapers as mandated.